Warshavsky Ori - 18 Mar 2026 Form 3 Insider Report for PolyPid Ltd. (PYPD)

Reporting relationship
Chief Operating Officer - US
Issuer ticker
PYPD
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
26 Mar 2026, 16:01:03 UTC
Next SEC filing
17 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ori Warshavsky

Key filing fact

Warshavsky Ori filed Form 3 for PolyPid Ltd. (PYPD) on 26 Mar 2026.

Key facts

  • This page summarizes Warshavsky Ori's Form 3 filing for PolyPid Ltd. (PYPD).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 26 Mar 2026, 16:01.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002124655 Primary reporting owner

Warshavsky Ori

Relationship
Chief Operating Officer - US
Address
C/O POLYPID LTD., 18 HASIVIM STREET ISRAEL, PETACH TIKVA, ISRAEL
Signature
/s/ Ori Warshavsky
Signature date
26 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PYPD holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
267
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,333
Exercise price
$23.07
Footnotes
F1
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,333
Exercise price
$23.07
Footnotes
F2
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
794
Exercise price
$23.07
Footnotes
F3
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
7,667
Exercise price
$11.01
Footnotes
F4
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
51,000
Exercise price
$4.64
Footnotes
F5
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
34,000
Exercise price
$4.64
Footnotes
F6
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
37,800
Exercise price
$2.67
Footnotes
F7
PYPD holding Derivative

Employee Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
25,200
Exercise price
$2.67
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The options were granted on November 9, 2020 and fully vested as of October 1, 2023.

Footnote F2

The options were granted on May 9, 2022 and vest on a quarterly basis beginning May 9, 2023 until May 9, 2026.

Footnote F3

The options were granted on August 9, 2021 and fully vested as of August 9, 2025.

Footnote F4

The options were granted on August 7, 2023 and vest on a quarterly basis beginning August 7, 2024 until August 7, 2027.

Footnote F5

The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2028.

Footnote F6

The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2026.

Footnote F7

The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2029.

Footnote F8

The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .